Abstract

Background and Aims

Treatment with high-volume HDF is associated with a better survival than standard HD. The underlying mechanism is unknown, but may depend on a lower level of intra-dialytic tissue damage. We compared tissue injury, as measured by the release of EVs during four dialysis treatment modalities.

Method

Chronic hemodialysis (CHD) patients were included in an open, cross-over, randomized fashion (n=14). EV release was measured by a calibrated flow cytometer (Apogee A-60) after antibody labeling. EVs are defined as cell-derived particles with a diameter <1.000nm and a refraction index (RI) <1.42. Two HD modalities were studied: sHD, t dialysate 36,5°C (sHD) and cHD, t dialysate 35,5°C and two HDF modalities (t dialysate 36,5°C): lvHDF with a convection volume (CV) <15 L/session and hvHDF with a CV >23 L/session.To establish the cellular origin of EVs, EVs were labelled with (anti-) CD45 (leukocytes), CD62e (activated endothelial cells), CD62p (activated platelets), CD144 (vascular endothelial cadherin), CD61 (platelets), CD235a (erythrocytes) and connexin-43 (myocardial and endothelial cells), and with the general EV marker lactadherin. Differences between the 4 dialysis modalities were investigated by comparing pre- and post-dialysis and the delta (post- minus pre-dialysis) EV concentrations by Friedman’s test.

Results

As shown in the figures below, CD61, lactadherin and CD144 increased during the 4 modalities (1=sHD,2=cHD,3=lvHDF,4=hvHDF). The overall increase (sum of all modalities) in connexin-43. In Table 1, the concentrations of EVs before- and after dialysis are shown with a p-value for the difference (post- minus pre-dialysis). No significant differences were found in pre- and post-dialysis and delta EV concentrations between the 4 dialysis modalities (data not shown).

Conclusion

From this analysis the following conclusions can be drawn: 1) except for CD62e, which declined, all measured EVs increased significantly during dialysis (Table 1). 2) Although not all EVs increased similarly during the 4 modalities (Fig 1), in terms of tissue damage no modality appears more advantageous than the other.

Absolute EV concentrations (mL-1) before and after dialysis: a:CD61, b:connexin-43, c:lactadherin, d:CD144. RI<1.42 (refraction index). Modality of dialysis (1= sHD, 2= cHD, 3= lvHDF, 4= hvHDF).
Figure 1:

Absolute EV concentrations (mL-1) before and after dialysis: a:CD61, b:connexin-43, c:lactadherin, d:CD144. RI<1.42 (refraction index). Modality of dialysis (1= sHD, 2= cHD, 3= lvHDF, 4= hvHDF).

Table 1:

intradialytic EV changes: means of 4 modalities, delta’s and p-values post vs pre-dialysis

EV concentration ( 107/mL)Pre-dialysisPost-dialysisdeltap-value (post- vs pre)

CD45

0.277

0.337

0.060

<0.0005

CD610.3970.9320.535<0.0005
CD62p0.0310.0740.043<0.0005
CD235a0.8391.5700.731<0.0005
CD62e0.9910.048-0.9430.03
CD1440.0210.1630.1420.03
Connexin-43+0.0980.2820.1840.002
Lactadherin2.8265.1762.35<0.0005
EV concentration ( 107/mL)Pre-dialysisPost-dialysisdeltap-value (post- vs pre)

CD45

0.277

0.337

0.060

<0.0005

CD610.3970.9320.535<0.0005
CD62p0.0310.0740.043<0.0005
CD235a0.8391.5700.731<0.0005
CD62e0.9910.048-0.9430.03
CD1440.0210.1630.1420.03
Connexin-43+0.0980.2820.1840.002
Lactadherin2.8265.1762.35<0.0005
Table 1:

intradialytic EV changes: means of 4 modalities, delta’s and p-values post vs pre-dialysis

EV concentration ( 107/mL)Pre-dialysisPost-dialysisdeltap-value (post- vs pre)

CD45

0.277

0.337

0.060

<0.0005

CD610.3970.9320.535<0.0005
CD62p0.0310.0740.043<0.0005
CD235a0.8391.5700.731<0.0005
CD62e0.9910.048-0.9430.03
CD1440.0210.1630.1420.03
Connexin-43+0.0980.2820.1840.002
Lactadherin2.8265.1762.35<0.0005
EV concentration ( 107/mL)Pre-dialysisPost-dialysisdeltap-value (post- vs pre)

CD45

0.277

0.337

0.060

<0.0005

CD610.3970.9320.535<0.0005
CD62p0.0310.0740.043<0.0005
CD235a0.8391.5700.731<0.0005
CD62e0.9910.048-0.9430.03
CD1440.0210.1630.1420.03
Connexin-43+0.0980.2820.1840.002
Lactadherin2.8265.1762.35<0.0005
This content is only available as a PDF.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.